Literature DB >> 3366226

Liver involvement at diagnosis of primary myelofibrosis: a clinicopathological study of twenty-two cases.

A Pereira1, M Bruguera, F Cervantes, C Rozman.   

Abstract

Liver biopsies were carried out at diagnosis in 22 patients with primary myelofibrosis. Pathological changes were semiquantitatively evaluated and correlated with either liver function tests, peripheral blood features, bone marrow biopsy changes or patient survival. Hepatic myeloid metaplasia (HMM), primarily consisting of the presence of morphologically abnormal megakaryocytes, was found in all cases. Other remarkable pathological changes included increased reticulin network, sinusoidal widening not related to the intensity of HMM, and iron overload in the absence of previous blood transfusions. High serum alkaline phosphatase was the most frequent biochemical abnormality, and reflected rather the presence of sinusoidal widening than the degree of HMM. The number of immature myeloid cells was the only peripheral blood parameter positively correlated with the degree of HMM. No relationship could be established between bone marrow changes and the degree of HMM. Finally, patients with mild HMM survived longer than those showing marked HMM.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366226     DOI: 10.1111/j.1600-0609.1988.tb00191.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.

Authors:  Matthew Yan; Holly Geyer; Ruben Mesa; Ehab Atallah; Jeannie Callum; Justyna Bartoszko; Karen Yee; Manjula Maganti; Florence Wong; Vikas Gupta
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-06-11

Review 2.  Liver in systemic disease.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

3.  Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients.

Authors:  M C Souza; C A Rodrigues; M R R Silva; J Ribeiro; R Tognon; F A Castro; B P Simões; E X Souto; M L Chauffaille
Journal:  Med Oncol       Date:  2013-04-09       Impact factor: 3.064

4.  Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.

Authors:  Tariq I Mughal; Kris Vaddi; Nicholas J Sarlis; Srdan Verstovsek
Journal:  Int J Gen Med       Date:  2014-01-29

5.  Liver function test abnormalities and their clinical relevance in primary myelofibrosis.

Authors:  D Barraco; M Mudireddy; S Shah; C A Hanson; R P Ketterling; N Gangat; A Pardanani; A Tefferi
Journal:  Blood Cancer J       Date:  2017-04-21       Impact factor: 11.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.